121 related articles for article (PubMed ID: 35801421)
1. Clinicopathological characteristics of individuals with coexisting melanoma and chronic lymphocytic leukaemia: a multicentre cohort study.
Fisher RM; Ji-Xu A; Abbott R; Basu T; Brown A; Foley C; Glen C; Gupta G; Hasan Z; Ismail F; Khalid A; Khoo ABS; Koumaki D; Lally A; Lear JT; McGrath EJ; McKenna K; Milligan A; Mulholland O; Tasker F; Harwood CA; Proby CM; Matin RN
Clin Exp Dermatol; 2022 Nov; 47(11):1976-1981. PubMed ID: 35801421
[TBL] [Abstract][Full Text] [Related]
2. A collision of diseases: chronic lymphocytic leukemia discovered during lymph node biopsy for melanoma.
Farma JM; Zager JS; Barnica-Elvir V; Puleo CA; Marzban SS; Rollison DE; Messina JL; Sondak VK
Ann Surg Oncol; 2013 Apr; 20(4):1360-4. PubMed ID: 23179994
[TBL] [Abstract][Full Text] [Related]
3. Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia.
Velez NF; Karia PS; Vartanov AR; Davids MS; Brown JR; Schmults CD
JAMA Dermatol; 2014 Mar; 150(3):280-7. PubMed ID: 24429548
[TBL] [Abstract][Full Text] [Related]
4. Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland.
McKenna DB; Stockton D; Brewster DH; Doherty VR
Br J Cancer; 2003 Jan; 88(1):74-8. PubMed ID: 12556962
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of melanoma in patients with chronic lymphocytic leukaemia: systematic review and meta-analysis of cohort studies.
Olsen CM; Lane SW; Green AC
Melanoma Res; 2016 Apr; 26(2):188-94. PubMed ID: 26630660
[TBL] [Abstract][Full Text] [Related]
6. Melanoma and CLL co-occurrence and survival: role of KC history.
Zhao Y; Amorrortu RP; Stewart SC; Ghia KM; Williams VL; Sondak VK; Tsai KY; Pinilla-Ibarz J; Chavez JC; Rollison DE
BMC Cancer; 2023 Nov; 23(1):1084. PubMed ID: 37946198
[TBL] [Abstract][Full Text] [Related]
7. Frequency and timing of other primary cancers in patients with chronic lymphocytic leukemia (CLL): a 17-year longitudinal study.
Akhtar OS; Groman A; Singh A; Ghione P; Lund I; Hernandez-Ilizaliturri FJ; Torka P
Leuk Lymphoma; 2022 May; 63(5):1127-1136. PubMed ID: 35152821
[TBL] [Abstract][Full Text] [Related]
8. Melanoma in patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma.
Famenini S; Martires KJ; Zhou H; Xavier MF; Wu JJ
J Am Acad Dermatol; 2015 Jan; 72(1):78-84. PubMed ID: 25440434
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous malignancies in chronic lymphocytic leukemia.
Zilberg C; Ferguson AL; Lyons JG; Gupta R; Fuller SJ; Damian DL
J Dermatol; 2024 Mar; 51(3):353-364. PubMed ID: 38291978
[TBL] [Abstract][Full Text] [Related]
10. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
[TBL] [Abstract][Full Text] [Related]
11. Impact of chronic lymphocytic leukaemia on melanoma outcomes: A retrospective case-control study.
Jobson D; McCormack CJ; Mar V; Tam C; Henderson MA
Br J Haematol; 2022 May; 197(3):320-325. PubMed ID: 35286715
[TBL] [Abstract][Full Text] [Related]
12. The risk of melanoma in patients with chronic lymphocytic leukemia; a population-based study.
Turk T; Saad AM; Al-Husseini MJ; Gad MM
Curr Probl Cancer; 2020 Apr; 44(2):100511. PubMed ID: 32115255
[TBL] [Abstract][Full Text] [Related]
13. Management of melanoma in patients with chronic lymphocytic leukemia.
Archibald WJ; Meacham PJ; Williams AM; Baran AM; Victor AI; Barr PM; Sahasrahbudhe DM; Zent CS
Leuk Res; 2018 Aug; 71():43-46. PubMed ID: 30005183
[TBL] [Abstract][Full Text] [Related]
14. Spindle cell melanoma coexisting with chronic lymphocytic leukemia/small lymphocytic lymphoma: a rare collision tumor in multiple sites.
Dirilenoglu F; Yukselen OO; Mocan G
J Cutan Pathol; 2020 Dec; 47(12):1215-1219. PubMed ID: 32959377
[TBL] [Abstract][Full Text] [Related]
15. Effects of chronic lymphocytic leukemia on the development and progression of malignant melanoma.
Brewer JD; Christenson LJ; Weenig RH; Weaver AL
Dermatol Surg; 2010 Mar; 36(3):368-76. PubMed ID: 20100262
[TBL] [Abstract][Full Text] [Related]
16. Chronic lymphocytic leukemia is associated with decreased survival of patients with malignant melanoma and Merkel cell carcinoma in a SEER population-based study.
Brewer JD; Shanafelt TD; Otley CC; Roenigk RK; Cerhan JR; Kay NE; Weaver AL; Call TG
J Clin Oncol; 2012 Mar; 30(8):843-9. PubMed ID: 22331952
[TBL] [Abstract][Full Text] [Related]
17. Margins of excision for cutaneous melanoma of the eyelid skin: the Collaborative Eyelid Skin Melanoma Group Report.
Esmaeli B; Youssef A; Naderi A; Ahmadi MA; Meyer DR; McNab A;
Ophthalmic Plast Reconstr Surg; 2003 Mar; 19(2):96-101. PubMed ID: 12644753
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for the development of locoregional cutaneous metastases as the sole form of recurrence in patients with melanoma.
Messeguer F; Agustí-Mejías A; Traves V; Alegre V; Oliver V; Nagore E
Actas Dermosifiliogr; 2013 Jan; 104(1):53-60. PubMed ID: 23010018
[TBL] [Abstract][Full Text] [Related]
19. Leukemia cutis coexisting with dermatofibroma as the initial presentation of B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma.
Maughan C; Kolker S; Markus B; Young J
Am J Dermatopathol; 2014 Jan; 36(1):e14-5. PubMed ID: 23974225
[TBL] [Abstract][Full Text] [Related]
20. Risk factors of recurrence and distant metastasis in primary cutaneous melanoma in Taiwan.
Lee TL; Liao YH; Liau JY; Sheen YS
Sci Rep; 2021 Oct; 11(1):21012. PubMed ID: 34697327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
